STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ONCY ONCOLYTICS BIOTECH INCORPORATED StockScouter® Report

5

StockScouter® Score

ONCOLYTICS BIOTECH INCORPORATED, a micro cap company in the healthcare sector, is expected to perform in line with the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • Shares are under accumulation by financial institutions. Marginally positive for a small company like ONCY

 

Concerns

  • Moving average analysis for ONCY suggests weak price movement over the medium term. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 60% done.
Low
High

Core Model Grades

B
C
N/A
F

Previous Ratings

7
8
6